vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and RH (RH). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $883.8M, roughly 1.1× RH). RH runs the higher net margin — 4.1% vs 0.7%, a 3.4% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 8.9%). RH produced more free cash flow last quarter ($83.0M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 9.4%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
RH is an upscale American home-furnishings company headquartered in Corte Madera, California. The company sells its merchandise through its retail stores, catalog, and online. As of August 2018, the company operated a total of 70 galleries, 18 full-line design galleries, and 3 baby-and-child galleries. The company also has 36 outlet stores in the United States and Canada.
ASTH vs RH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $883.8M |
| Net Profit | $6.6M | $36.3M |
| Gross Margin | — | 44.1% |
| Operating Margin | 1.9% | 12.0% |
| Net Margin | 0.7% | 4.1% |
| Revenue YoY | 42.9% | 8.9% |
| Net Profit YoY | 184.4% | 9.3% |
| EPS (diluted) | $0.12 | $1.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $883.8M | ||
| Q3 25 | $956.0M | $899.2M | ||
| Q2 25 | $654.8M | $814.0M | ||
| Q1 25 | $620.4M | $812.4M | ||
| Q4 24 | $665.2M | $811.7M | ||
| Q3 24 | $478.7M | $829.7M | ||
| Q2 24 | $486.3M | $727.0M | ||
| Q1 24 | $404.4M | $738.3M |
| Q4 25 | $6.6M | $36.3M | ||
| Q3 25 | $373.0K | $51.7M | ||
| Q2 25 | $9.4M | $8.0M | ||
| Q1 25 | $6.7M | $13.9M | ||
| Q4 24 | $-7.8M | $33.2M | ||
| Q3 24 | $16.1M | $29.0M | ||
| Q2 24 | $19.2M | $-3.6M | ||
| Q1 24 | $14.8M | $11.4M |
| Q4 25 | — | 44.1% | ||
| Q3 25 | — | 45.5% | ||
| Q2 25 | — | 43.7% | ||
| Q1 25 | — | 44.7% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 45.2% | ||
| Q2 24 | — | 43.5% | ||
| Q1 24 | — | 43.5% |
| Q4 25 | 1.9% | 12.0% | ||
| Q3 25 | 2.0% | 14.3% | ||
| Q2 25 | 3.1% | 6.9% | ||
| Q1 25 | 3.3% | 8.7% | ||
| Q4 24 | 0.1% | 12.5% | ||
| Q3 24 | 5.9% | 11.6% | ||
| Q2 24 | 6.2% | 7.5% | ||
| Q1 24 | 7.5% | 8.7% |
| Q4 25 | 0.7% | 4.1% | ||
| Q3 25 | 0.0% | 5.8% | ||
| Q2 25 | 1.4% | 1.0% | ||
| Q1 25 | 1.1% | 1.7% | ||
| Q4 24 | -1.2% | 4.1% | ||
| Q3 24 | 3.4% | 3.5% | ||
| Q2 24 | 3.9% | -0.5% | ||
| Q1 24 | 3.7% | 1.5% |
| Q4 25 | $0.12 | $1.83 | ||
| Q3 25 | $0.01 | $2.62 | ||
| Q2 25 | $0.19 | $0.40 | ||
| Q1 25 | $0.14 | $0.71 | ||
| Q4 24 | $-0.14 | $1.66 | ||
| Q3 24 | $0.33 | $1.45 | ||
| Q2 24 | $0.40 | $-0.20 | ||
| Q1 24 | $0.31 | $0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $43.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $3.3M |
| Total Assets | $2.2B | $4.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $43.1M | ||
| Q3 25 | $463.4M | $34.6M | ||
| Q2 25 | $342.1M | $46.1M | ||
| Q1 25 | $260.9M | $30.4M | ||
| Q4 24 | $290.8M | $87.0M | ||
| Q3 24 | $350.3M | $78.3M | ||
| Q2 24 | $327.7M | $101.8M | ||
| Q1 24 | $337.3M | $123.7M |
| Q4 25 | $779.3M | $3.3M | ||
| Q3 25 | $775.5M | $-40.9M | ||
| Q2 25 | $765.5M | $-110.8M | ||
| Q1 25 | $745.4M | $-163.6M | ||
| Q4 24 | $712.7M | $-183.0M | ||
| Q3 24 | $704.6M | $-234.7M | ||
| Q2 24 | $678.9M | $-289.9M | ||
| Q1 24 | $653.5M | $-297.4M |
| Q4 25 | $2.2B | $4.8B | ||
| Q3 25 | $2.2B | $4.7B | ||
| Q2 25 | $1.4B | $4.7B | ||
| Q1 25 | $1.3B | $4.6B | ||
| Q4 24 | $1.4B | $4.5B | ||
| Q3 24 | $1.3B | $4.4B | ||
| Q2 24 | $1.3B | $4.2B | ||
| Q1 24 | $1.2B | $4.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $131.9M |
| Free Cash FlowOCF − Capex | $-6.0M | $83.0M |
| FCF MarginFCF / Revenue | -0.6% | 9.4% |
| Capex IntensityCapex / Revenue | 0.3% | 5.5% |
| Cash ConversionOCF / Net Profit | -0.44× | 3.64× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $128.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $131.9M | ||
| Q3 25 | $10.0M | $137.7M | ||
| Q2 25 | $90.9M | $86.6M | ||
| Q1 25 | $16.6M | $-18.8M | ||
| Q4 24 | $-10.9M | $-31.4M | ||
| Q3 24 | $34.0M | $11.2M | ||
| Q2 24 | $23.2M | $56.1M | ||
| Q1 24 | $6.0M | $-114.0M |
| Q4 25 | $-6.0M | $83.0M | ||
| Q3 25 | $7.4M | $80.7M | ||
| Q2 25 | $89.5M | $34.1M | ||
| Q1 25 | $13.6M | $-69.7M | ||
| Q4 24 | $-13.5M | $-96.0M | ||
| Q3 24 | $31.7M | $-37.9M | ||
| Q2 24 | $20.4M | $-10.1M | ||
| Q1 24 | $5.6M | $-251.5M |
| Q4 25 | -0.6% | 9.4% | ||
| Q3 25 | 0.8% | 9.0% | ||
| Q2 25 | 13.7% | 4.2% | ||
| Q1 25 | 2.2% | -8.6% | ||
| Q4 24 | -2.0% | -11.8% | ||
| Q3 24 | 6.6% | -4.6% | ||
| Q2 24 | 4.2% | -1.4% | ||
| Q1 24 | 1.4% | -34.1% |
| Q4 25 | 0.3% | 5.5% | ||
| Q3 25 | 0.3% | 6.3% | ||
| Q2 25 | 0.2% | 6.5% | ||
| Q1 25 | 0.5% | 6.3% | ||
| Q4 24 | 0.4% | 8.0% | ||
| Q3 24 | 0.5% | 5.9% | ||
| Q2 24 | 0.6% | 9.1% | ||
| Q1 24 | 0.1% | 18.6% |
| Q4 25 | -0.44× | 3.64× | ||
| Q3 25 | 26.69× | 2.66× | ||
| Q2 25 | 9.65× | 10.78× | ||
| Q1 25 | 2.48× | -1.35× | ||
| Q4 24 | — | -0.95× | ||
| Q3 24 | 2.11× | 0.39× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | -10.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
RH
| RH Segment | $835.8M | 95% |
| Waterworks Segment | $48.0M | 5% |
| Gift Card And Merchandise Credit | $4.5M | 1% |
